InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Saadikh Usamakh. Director active across 1 company, notably CEN Biotech INC. Cumulatively, 2 reports have been recorded. History available since 2 April 2021. The latest transaction was disclosed on 2 April 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations